Glyburide
- Product NDC
- 0093-8342
- 11-digit product format
- 000938342
- Labeler code
- 0093
- Product ID
- 0093-8342_f4b5b433-1b6e-4af2-9d16-7194c2da041c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA074388
- Marketing category
- ANDA
- Marketing start
- 1995-08-30
- Substance
- GLYBURIDE
- Active strength
- 1.25 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glyburide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLYBURIDE | 1.25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SX6K58TVWC |
| Rxcui | 197737, 310534, 310537 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-8342-01 | Glyburide | 100 in 1 BOTTLE | TABLET | 100 | | 18 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-8342 | GLYBURIDE TABLET [TEVA PHARMACEUTICALS USA, INC.] | 18 | Current NDC, Legacy NDC, 1 package rows | 20211030_a56f100f-0f42-4188-81ab-04644b824040.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-8342-01 | 00093834201 | 100 TABLET in 1 BOTTLE (0093-8342-01) | 100 tablet | 1995-08-30 | 0000-00-00 | No | No | Current |